Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Carfilzomib for the Treatment of T-Cell Lymphoma

NCT01336920 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT01336920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01336920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Carfilzomib for the Treatment of T-Cell Lymphoma
Lead sponsor
University of Nebraska
Phase
Phase 1
Overall status
Completed
Start date
June 21, 2011
Completion date
March 1, 2018
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adult nasal type extranodal nk/t-cell lymphoma, anaplastic large cell lymphoma, angioimmunoblastic t-cell lymphoma, peripheral t-cell lymphoma, recurrent adult t-cell leukemia/lymphoma